Immunobiology of MINA53
MINA53 的免疫生物学
基本信息
- 批准号:7712947
- 负责人:
- 金额:$ 29.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-23 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesAllergensAllergicAsthmaAutoimmune DiseasesBindingBiological AssayBloodCD4 Positive T LymphocytesCase-Control StudiesCellsChildClinicCrowsDataDevelopmentDiagnosticDiseaseDisease AssociationEMSAEnrollmentEtiologyEvaluationFamily memberFrequenciesGeneral PopulationGenesGenetic MarkersGenetic TranscriptionGovernmentHelper-Inducer T-LymphocyteHereditary DiseaseHistonesHumanHuman GeneticsIL4 geneImmune responseImmunobiologyIndividualInterleukin 4 ReceptorInterleukin-13LifeLinkage DisequilibriumMainstreamingMethodsMolecular GeneticsMono-SMusMutationNuclear AntigensPersonsProtein FamilyReporterResearch PersonnelRiskRisk FactorsRoleSumT-LymphocyteTestingTherapeutic InterventionTolerogenTransgenic AnimalsVariantYinbasechromatin immunoprecipitationcohortdisorder riskgenetic associationgenetic regulatory proteinhealthy volunteerhuman diseasenovelpathogenpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): In humans, IL4 and TH2 cells critically impact a wide array of diseases, a prime example of which is bronchial asthma where genetic association studies have repeatedly identified both the gene locus encoding IL4 and IL13 (5q25-31) and several mutations in the IL4 receptor alpha chain as strong disease risk factors REF. We recently identified Mina53 as a gene in mice encoding an IL4 regulatory protein that cell autonomously regulates TH2 bias, the propensity of naive CD4 cells to develop into IL4 secreting TH2 cells [1]. Mina53, first identified as a Myc-induced nuclear antigen of 53kd [2], belongs to the Jmj protein family whose hallmark JmjC domain was shown recently in multiple family members to possess histone demethylase activity [3-9]. Murine Mina53 is induced rapidly in naive T helper cells to levels that are inversely correlated with those of IL4, being high in low-TH2 biased strains and low in high-TH2 biased strains, suggesting an IL4/TH2 inhibitory role. Consistent with this, EMSA, chromatin immunoprecipitation (ChIP), transient reporter and transgenic animal assays demonstrate that Mina53 specifically binds to and represses transcription from the IL4 gene. Together, these data support the central hypothesis of this proposal that in human T cells, MINA53 represses IL4 expression, thereby critically influencing TH2 development and TH2-dependent disease. We will test this hypothesis by determining: (1) the role of MINA53 in regulating IL4 and TH2 bias in human T helper cells; and (2) whether variation in the MINA53 locus associates with the TH2-dependent disease bronchial asthma. The long-term objective of this proposal is to understand the molecular and genetic basis for IL4/TH2- dependent disease and to identify novel targets for diagnostic and therapeutic intervention. PUBLIC HEALTH RELEVANCE: The global significance of this proposal arises from the critical role of TH2 bias in immune responses elicited by tolerogens, pathogens and allergens. Deeper mechanistic understanding of TH2 bias and its role in bronchial asthma may provide new targets for diagnostic and therapeutic interventions for asthma as well as for other TH2-dependent disease of autoimmune, infectious and allergic etiology affecting the lives of millions of people.
描述(申请人提供):在人类中,IL 4和TH 2细胞严重影响多种疾病,其中一个最好的例子是支气管哮喘,其中遗传关联研究反复鉴定了编码IL 4和IL 13的基因位点(5 q25 -31)和IL 4受体α链中的几个突变作为强烈的疾病风险因素REF。我们最近在小鼠中鉴定了Mina 53作为编码IL 4调节因子的基因。细胞自主调节TH 2偏好的蛋白质,幼稚CD 4细胞发育成分泌IL 4的TH 2细胞的倾向[1]。Mina 53首先被鉴定为Myc诱导的53 kd的核抗原[2],属于Jmj蛋白家族,其标志性JmjC结构域最近在多个家族成员中显示具有组蛋白脱甲基酶活性[3-9]。小鼠Mina 53在初始T辅助细胞中被快速诱导至与IL 4的水平负相关的水平,在低TH 2偏向的菌株中高而在高TH 2偏向的菌株中低,表明IL 4/TH 2抑制作用。与此一致,EMSA、染色质免疫沉淀(ChIP)、瞬时报告基因和转基因动物测定证明Mina 53特异性结合IL 4基因并抑制IL 4基因的转录。总之,这些数据支持了该提议的中心假设,即在人T细胞中,MINA 53抑制IL 4表达,从而严重影响TH 2发育和TH 2依赖性疾病。我们将通过以下方法来检验这一假设:(1)MINA 53在调节人辅助性T细胞中IL 4和TH 2偏好中的作用;(2)MINA 53基因座的变异是否与TH 2依赖性支气管哮喘相关。该提案的长期目标是了解IL 4/TH 2依赖性疾病的分子和遗传基础,并确定诊断和治疗干预的新靶点。公共卫生关系:这一提议的全球意义源于TH 2偏好在耐受原、病原体和过敏原引起的免疫应答中的关键作用。对TH 2偏倚及其在支气管哮喘中的作用的更深入的机制理解可能为哮喘以及影响数百万人生活的其他自身免疫性、感染性和过敏性病因的TH 2依赖性疾病的诊断和治疗干预提供新的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Bix其他文献
Mark Bix的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Bix', 18)}}的其他基金
Genetic Basis For Predisposition To Immune Based Disease
免疫性疾病易感性的遗传基础
- 批准号:
8511228 - 财政年份:2013
- 资助金额:
$ 29.4万 - 项目类别:
Genetic Basis For Predisposition To Immune Based Disease
免疫性疾病易感性的遗传基础
- 批准号:
8604372 - 财政年份:2013
- 资助金额:
$ 29.4万 - 项目类别:
ENVIRONMENT AND EPIGENETIC CONTROL OF IMMUNE RESPONSES
免疫反应的环境和表观遗传控制
- 批准号:
6712868 - 财政年份:2003
- 资助金额:
$ 29.4万 - 项目类别:
ENVIRONMENT AND EPIGENETIC CONTROL OF IMMUNE RESPONSES
免疫反应的环境和表观遗传控制
- 批准号:
6561202 - 财政年份:2003
- 资助金额:
$ 29.4万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 29.4万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 29.4万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 29.4万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 29.4万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 29.4万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 29.4万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 29.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 29.4万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 29.4万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 29.4万 - 项目类别: